Merck Reports Strong Q3 Despite Hepat...

Merck Reports Strong Q3 Despite Hepatitis C Battle With Vertex

There are 1 comment on the Seeking Alpha story from Oct 28, 2011, titled Merck Reports Strong Q3 Despite Hepatitis C Battle With Vertex. In it, Seeking Alpha reports that:

Vertex's announced remarkable results of sales of hepatitis C treatment Incivek.

Join the discussion below, or Read more at Seeking Alpha.

Gary

Toronto, Canada

#1 Nov 1, 2011

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Vertex Pharmaceuticals Discussions

Title Updated Last By Comments
News Feuerstein's Biotech Mailbag (Mar '07) Mar '16 Janice 3
News Vertex Pharmaceuticals (MA) Seeks FDA Green Lig... (Nov '10) Mar '16 Sherril 2
News FDA clears drug for leading form of cystic fibr... (Jul '15) Jul '15 Chloe Mica 1
News Seaport parking becomes a hot commodity (Jun '14) Jun '14 Doug 1
News Vertex, Biogen make list of most productive dru... (Jun '14) Jun '14 Doug 1
News Vertex to Present at the Goldman Sachs Global H... (Jun '14) Jun '14 Doug 1
News Price of cystic fibrosis drug Kalydeco could dr... (Jun '14) Jun '14 Doug 1
More from around the web